OBJECTIVE: To estimate the impact of antiretroviral therapy (ART) on population-wide adult life expectancy. STUDY DESIGN: A population-based open cohort study with repeated HIV status measurements and registration of vital events in Southwestern Uganda (1991-2012). METHODS: Nonparametric survival analysis techniques are used for estimating trends in the adult life expectancy of the general population (aged 15 and above), the adult life expectancy by HIV status, and the adult life expectancy deficit. The life expectancy deficit is estimated as the difference between overall life expectancy and life expectancy of the HIV-negative population. All estimates are disaggregated by sex. RESULTS: Between 1991-1993 and 2009-2012, population-wide adult life expectancy increased from 39.3 [95% confidence interval (CI): 35.9-42.8] to 56.1 years (95% CI: 54.0-58.5) in women, and from 38.6 (95% CI: 35.4-42.1) to 51.4 years (95% CI: 49.2-53.7) in men. Most of the adult life expectancy gains coincide with the introduction of ART in 2004; as evidenced by an increase in the adult life expectancy of people living with HIV between 2000-2002 and 2009-2012 of 22.9 and 20.0 years for women and men, respectively. Over the whole period of observation, the adult life expectancy deficit associated with HIV decreased from 16.1 (95% CI: 12.7-19.8) to 6.0 years (95% CI: 4.1-7.8) among women, and from 16.0 (95% CI: 12.1-19.9) to 2.8 years (95% CI: 1.2-4.6) among men. CONCLUSION: Population-wide life expectancy increased substantially, largely driven by reductions in HIV-related mortality. Women have gained more adult life years than men since the introduction of ART, but the burden of HIV in terms of the life years lost is still larger for women than it is for men.
OBJECTIVE: To estimate the impact of antiretroviral therapy (ART) on population-wide adult life expectancy. STUDY DESIGN: A population-based open cohort study with repeated HIV status measurements and registration of vital events in Southwestern Uganda (1991-2012). METHODS: Nonparametric survival analysis techniques are used for estimating trends in the adult life expectancy of the general population (aged 15 and above), the adult life expectancy by HIV status, and the adult life expectancy deficit. The life expectancy deficit is estimated as the difference between overall life expectancy and life expectancy of the HIV-negative population. All estimates are disaggregated by sex. RESULTS: Between 1991-1993 and 2009-2012, population-wide adult life expectancy increased from 39.3 [95% confidence interval (CI): 35.9-42.8] to 56.1 years (95% CI: 54.0-58.5) in women, and from 38.6 (95% CI: 35.4-42.1) to 51.4 years (95% CI: 49.2-53.7) in men. Most of the adult life expectancy gains coincide with the introduction of ART in 2004; as evidenced by an increase in the adult life expectancy of people living with HIV between 2000-2002 and 2009-2012 of 22.9 and 20.0 years for women and men, respectively. Over the whole period of observation, the adult life expectancy deficit associated with HIV decreased from 16.1 (95% CI: 12.7-19.8) to 6.0 years (95% CI: 4.1-7.8) among women, and from 16.0 (95% CI: 12.1-19.9) to 2.8 years (95% CI: 1.2-4.6) among men. CONCLUSION: Population-wide life expectancy increased substantially, largely driven by reductions in HIV-related mortality. Women have gained more adult life years than men since the introduction of ART, but the burden of HIV in terms of the life years lost is still larger for women than it is for men.
Authors: Brent Wolff; Barbara Nyanzi; George Katongole; Deo Ssesanga; Anthony Ruberantwari; Jimmy Whitworth Journal: Health Policy Plan Date: 2005-03 Impact factor: 3.344
Authors: Simon Gregson; Constance A Nyamukapa; Geoffrey P Garnett; Peter R Mason; Tom Zhuwau; Michel Caraël; Stephen K Chandiwana; Roy M Anderson Journal: Lancet Date: 2002-06-01 Impact factor: 79.321
Authors: Gershim Asiki; Georgina Murphy; Jessica Nakiyingi-Miiro; Janet Seeley; Rebecca N Nsubuga; Alex Karabarinde; Laban Waswa; Sam Biraro; Ivan Kasamba; Cristina Pomilla; Dermot Maher; Elizabeth H Young; Anatoli Kamali; Manjinder S Sandhu Journal: Int J Epidemiol Date: 2013-01-30 Impact factor: 7.196
Authors: Georges Reniers; Emma Slaymaker; Jessica Nakiyingi-Miiro; Constance Nyamukapa; Amelia Catharine Crampin; Kobus Herbst; Mark Urassa; Fred Otieno; Simon Gregson; Maquins Sewe; Denna Michael; Tom Lutalo; Victoria Hosegood; Ivan Kasamba; Alison Price; Dorean Nabukalu; Estelle Mclean; Basia Zaba Journal: AIDS Date: 2014-11 Impact factor: 4.177
Authors: Andreas Jahn; Sian Floyd; Amelia C Crampin; Frank Mwaungulu; Hazzie Mvula; Fipson Munthali; Nuala McGrath; Johnbosco Mwafilaso; Venance Mwinuka; Bernard Mangongo; Paul E M Fine; Basia Zaba; Judith R Glynn Journal: Lancet Date: 2008-05-10 Impact factor: 79.321
Authors: Thomas Engell-Sørensen; Andreas Rieckmann; Candida Medina; David da Silva Té; Amabelia Rodrigues; Ane Bærent Fisker; Peter Aaby; Christian Erikstrup; Sanne Jespersen; Christian Wejse; Bo Langhoff Hønge Journal: Infection Date: 2021-02-02 Impact factor: 3.553
Authors: Alex Kayongo; Adaeze C Wosu; Tasmia Naz; Faith Nassali; Robert Kalyesubula; Bruce Kirenga; Robert A Wise; Trishul Siddharthan; William Checkley Journal: COPD Date: 2020-05-28 Impact factor: 2.409
Authors: Leigh F Johnson; Margaret T May; Rob E Dorrington; Morna Cornell; Andrew Boulle; Matthias Egger; Mary-Ann Davies Journal: PLoS Med Date: 2017-12-12 Impact factor: 11.069
Authors: Emma Slaymaker; Estelle McLean; Alison Wringe; Clara Calvert; Milly Marston; Georges Reniers; Chodziwadziwa Whiteson Kabudula; Amelia Crampin; Alison Price; Denna Michael; Mark Urassa; Daniel Kwaro; Maquins Sewe; Jeffrey W Eaton; Rebecca Rhead; Jessica Nakiyingi-Miiro; Tom Lutalo; Dorean Nabukalu; Kobus Herbst; Victoria Hosegood; Basia Zaba Journal: Gates Open Res Date: 2017-11-06
Authors: Georges Reniers; Sylvia Blom; Clara Calvert; Alexandra Martin-Onraet; Abraham J Herbst; Jeffrey W Eaton; Jacob Bor; Emma Slaymaker; Zehang R Li; Samuel J Clark; Till Bärnighausen; Basia Zaba; Victoria Hosegood Journal: Lancet HIV Date: 2016-12-10 Impact factor: 16.070